Endless Biotech Becomes First to Test Fohse’s State-of-the-Art A3i Pro Light Fixture

Tulsa, OK – [Date] – Endless Biotech ("Endless") is proud to announce that its research and development division has become the first cannabis cultivation operation in the world to receive and test FOHSE’s latest state-of-the-art light fixtures, the A3i Pros. This exclusive opportunity allows Endless to conduct research and development (R&D) on these cutting-edge lights and provide valuable feedback to FOHSE prior to mass distribution.

FOHSE, a leader in horticultural lighting, chose Endless for this pioneering partnership due to our reputation for innovation and excellence in cannabis cultivation. By leveraging Endless’s advanced tissue culture technology and cultivation expertise, FOHSE aims to refine preset spectrums for A3i Pro light fixtures to meet the highest standards of performance and efficiency.

"This collaboration with FOHSE is a testament to the strong relationship we have built and our mutual commitment to driving innovation in the cannabis industry," said Travis Dahm, CEO of Endless Biotech. "We are honored to be the first to test the A3i Pros and contribute to their development. This partnership not only enhances our cultivation capabilities but also positions us at the forefront of technological advancements in the global cannabis market."

The A3i Pro light fixtures represent the latest in FOHSE’s portfolio of advanced horticultural lighting solutions, designed to optimize plant growth and maximize yield. Endless Biotech will utilize these lights in its state-of-the-art facility, conducting rigorous testing and analysis to ensure they meet the demanding needs of modern cannabis cultivation.

"Endless Biotech’s expertise and cutting-edge approach to cultivation make them the ideal partner for testing our A3i Pro lights," said a spokesperson for FOHSE. "Their feedback will be invaluable as we finalize the design and prepare for mass distribution. This collaboration exemplifies our commitment to innovation and our goal of providing the best possible lighting solutions to the horticulture industry."

This partnership underscores the synergy between Endless Biotech and FOHSE, highlighting their joint efforts to revolutionize the cannabis cultivation landscape. By working together, both companies aim to set new benchmarks in quality, efficiency, and sustainability, ultimately benefiting growers worldwide.

About Endless Biotech

Endless Biotech is a leader in cannabis cultivation, specializing in pharmaceutical-grade tissue cultures and clone genetics. With a mission to provide disease- and pest-free cannabis plants, Endless combines pioneering science and cutting-edge technology to serve grow operations globally. The company’s team includes world-renowned scientists and researchers dedicated to advancing the cannabis industry.

About Fohse

FOHSE (Full On High Spectrum Energy) is an industry leader in innovative horticultural lighting solutions. Known for their advanced LED technologies, FOHSE provides high-performance lighting systems designed to optimize plant growth and maximize yields for growers worldwide.

Forward Looking Statements

This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the launch of Cross Marketing & Strategic Partners initiatives. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Securities & Exchange Committee (SEC) has not reviewed, approved or disapproved the content of this news release.